Protein Sciences and Passport Health team up on Flublok; MicroVAX begins cancer vax trial;

> Protein Sciences and Passport Health have teamed up to offer the Flublok flu vaccine at more than 230 Passport Health locations across the U.S. Release

> MicroVAX has begun a Phase I trial for its cancer vaccine platform for patients with breast, prostate, colon, ovary and lung cancers that have relapsed after initial therapy. Report

> In a U.K. study, researchers from the University of Southampton found that two new meningitis vaccines, Novartis' Menveo (MenACWY-CRM) and Bexsero (4CMenB), prevented the transmission of meningitis bacteria by up to 40%.

And Finally... Up to 30,000 people could have used experimental treatments or vaccines so far in the world's worst outbreak of Ebola, British scientists say. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.